Physician profile
Vito Ferrucci
NPI 1023101292
$772.02
in general payments reported to CMS, 2019-2025
13 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.69 · 2021: $27.52 · 2022: $35.69 · 2023: $231 · 2024: $165 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $148.17 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $131.92 | 2024-2025 | Ova1 |
| Mayne Pharma Commercial LLC | $84.76 | 2023-2025 | |
| Abbvie INC. | $73.95 | 2023-2024 | |
| Avion Pharmaceuticals | $66.21 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $64.84 | 2022-2023 | Gardasil 9 |
| Pfizer INC. | $58.09 | 2023-2024 | |
| Exact Sciences Corporation | $37.94 | 2025 | Cologuard Collection Kit |
| Myriad Women'S Health, INC. | $28.63 | 2023 | |
| Astellas Pharma US INC | $23.49 | 2023 | Veozah |
| Scynexis, INC. | $21.60 | 2022 | |
| Organon LLC | $18.80 | 2025 | Nexplanon |
| Coopersurgical, INC. | $13.62 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vito Ferrucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.